Ignazio Giannone
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
Papers in
-
- Drug Solubulity and Delivery Systems 4
- Advanced Drug Delivery Systems 4
- Advancements in Transdermal Drug Delivery 3
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Giovanni Puglisi (10 shared papers)Cinzia Anna Ventura (8 shared papers)Teresa Musumeci (5 shared papers)Rosario Pignatello (5 shared papers)Lucia Montenegro (2 shared papers)Barbara Ruozi (1 shared paper)Donatella Paolino (3 shared papers)S. Tommasini (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (2 papers)International Journal of Pharmaceutics (2 papers)Colloids and Surfaces B Biointerfaces (1 paper)BMC Cancer (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- Italy
In The Last Decade
Ignazio Giannone
11 papers receiving 645 citations
Peers
Comparison fields: 5 of 86
- Pharmaceutical Science 340
- Biomaterials 292
- Molecular Medicine 27
- Biomedical Engineering 143
- Organic Chemistry 71
Countries citing papers authored by Ignazio Giannone
This map shows the geographic impact of Ignazio Giannone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignazio Giannone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignazio Giannone more than expected).
Fields of papers citing papers by Ignazio Giannone
This network shows the impact of papers produced by Ignazio Giannone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignazio Giannone. The network helps show where Ignazio Giannone may publish in the future.
Co-authors
The 25 scholars most cited alongside Ignazio Giannone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 365 | |
| 2 | 2005 | 71 | |
| 3 | 2007 | 54 | |
| 4 | 2006 | 49 | |
| 5 | 2008 | 41 | |
| 6 | 2006 | 34 | |
| 7 | 2013 | 27 | |
| 8 | 2008 | 8 | |
| 9 | 2011 | 7 | |
| 10 | Use of solid phase extraction (SPE) to evaluate in vitro skin permeation of aescin. | 2007 | 4 |
| 11 | Technological evaluation and equivalence assessment of lorazepam tablets in rabbits. | 2007 | 1 |
About Ignazio Giannone
Ignazio Giannone is a scholar working on Pharmaceutical Science, Biomaterials, Organic Chemistry, Small Animals and Molecular Biology, having authored 11 papers that have together received 661 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (4 papers), Advanced Drug Delivery Systems (4 papers), Advancements in Transdermal Drug Delivery (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer Treatment and Pharmacology (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Ocular Surface and Contact Lens (1 paper) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Pharmaceutical Science (340 citations), Biomaterials (292 citations), Molecular Medicine (27 citations), Biomedical Engineering (143 citations) and Organic Chemistry (71 citations). Ignazio Giannone has collaborated with scholars based in Italy. Frequent co-authors include Giovanni Puglisi, Cinzia Anna Ventura, Teresa Musumeci, Rosario Pignatello, Lucia Montenegro, Barbara Ruozi, Donatella Paolino, S. Tommasini, Venerando Pistarà and Antonino Corsaro. Their work appears in journals such as European Journal of Medicinal Chemistry, International Journal of Pharmaceutics, Colloids and Surfaces B Biointerfaces, BMC Cancer and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.